*Correspondence: Hua Hao, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Ozempic is a once-weekly injectable form of semaglutide used to improve glycemic control in adults with T2DM and, when used in conjunction with diet and exercise, can reduce the risk of major cardiovascular events in individuals with established CVD.7 Typical dosing for Ozempic begins at 0.25 mg once weekly for four weeks to minimize gastrointestinal (GI) side effects, followed by 0.5 mg weekly, with the option to increase to 1 mg or 2 mg weekly depending on clinical response and glycemic control needs.7 Ozempic is often prescribed off-label for weight loss
Age Considerations Age is a significant factor, particularly for peptides that interact with the Growth Hormone axis
No studies have evaluated this practice, so I cannot speak to its effects in a controlled setting
11 "Insulin-Like Growth Factor-1 at Diagnosis and during
Mills GC (1957) Hemoglobin catabolism
